5 Top Trends to Watch at AACC 2017

The American Association for Clinical Chemistry (AACC) is about to host its 69th Annual Scientific Meeting & Clinical Lab Expo, which will take place from July 31 through August 4.

According to the AACC website, the expo showcases a variety of cutting-edge technology with more than 200 new product introductions each year. With so much happening in the field, what should attendees expect to see?

Topics: Diagnostics Kalorama Information

12 Leading Companies in Clinical Laboratory Services

Clinical laboratories are a critical component of health care. Approximately 80% of physicians’ diagnoses are a result of laboratory tests, according to Kalorama Information, a healthcare market research firm.

Common routine tests include cholesterol level tests, HIV tests, pap tests, pregnancy tests, and substance abuse tests. Clinical lab testing is also used to monitor diseases and drug treatments. Specialty testing, which is often more costly, may include genetics, immunology, oncology, endocrinology, and other segments.

Topics: Diagnostics Kalorama Information Industry Insights

3 Life Sciences Industry Reports by Kalorama Information

Kalorama Information provides life sciences industry research for leading drug, diagnostic, and medical device companies. Kalorama uses expert healthcare analysts who are highly knowledgeable and adept at discovering current trends. This publisher is regularly cited as a credible source by major news outlets such as The Wall Street Journal, Associated Press, The New York Times, Genetic Engineering News, Contract Pharma, and Becker’s Hospital Review.

This year, Kalorama Information has released a number of new market research reports on key diagnostics and medical device industries. Three major reports are profiled below.

Topics: Diagnostics Medical Devices Kalorama Information Industry Insights

9 Leading Companies in Direct-to-Consumer Genetic Testing

As patients take a more proactive role in their own health care, direct-to-consumer (DTC) laboratory testing is becoming increasingly popular. DTC genetic tests allow consumers to access information about their genetics without necessarily involving healthcare professionals in the process. 

A number of established and emerging companies are competing in this growing market. Kalorama Information, a healthcare market research firm owned by MarketResearch.com, recently profiled a variety of prominent market participants in its report The Market for Direct-to-Consumer Genetic Testing and Routine Laboratory Testing. This blog post highlights 9 of these companies that are among the leaders in the industry.

Topics: Diagnostics Healthcare Kalorama Information

4 Life Science White Papers to Download

MarketResearch.com is a leading provider of business intelligence, offering users access to timely information about hundreds of industries. In partnership with Kalorama Information, MarketResearch.com provides high-quality research and analysis to key decision makers in life science firms.

Life science market research includes broad topics such as biotechnology, healthcare, pharmaceuticals, medical devices, and diagnostics. New and established companies need to be aware of influential changes that may alter how healthcare is delivered and the patient's experience and outcomes. Our white papers and market research reports explain the market sectors and healthcare trends that matter most. Below is a list of our latest white papers with insights into this rapidly changing industry.

Topics: Diagnostics Healthcare Industry Insights

Growing In-Vitro Diagnostics (IVD) Markets in Asia

An essential component of clinical care, in-vitro diagnostics tests can detect a wide range of diseases, infections, and conditions, from sexually-transmitted diseases to different types of cancer.

In the next five to ten years, the in-vitro diagnostics markets (IVD) in Europe, Japan, and the U.S. are expected to experience only modest growth. In contrast, developing and emerging markets will drive increased demand for IVD as a growing middle class and aging population seek out healthcare services.

Topics: Diagnostics Industry Insights

An Investor’s Guide to Understanding Market Variation within the Global Cord Blood Industry

Market Variation within the Global Cord Blood Industry

Cord blood banks now exist within nearly every developed country, as well within most developing nations. However, there is still significant variation within the industry. First, there is the divide between private and public cord blood banking, in which private companies serve individual families, while public banks serve the broader population. Additionally, some cord blood banks receive only units from nearby hospitals and birthing centers, while others allow mail-in units from a diverse geographic region.
Topics: Diagnostics Biotechnology

Projected 2015 Trends in the Healthcare Industry

Healthcare market research publisher Kalorama Information has identified the top five trends in the healthcare field that made an impact in 2014 and will continue to be an influence throughout 2015. Kalorama compiled its list based on news events, growth rates of markets the firm studied in 2014, and information requests the firm receives from industry participants. 

Topics: Diagnostics Biotechnology Pharmaceuticals Healthcare Medical Devices

Diagnostics Industry Sees Growth From Emerging Markets

Growth in the $54.6 billion in vitro diagnostics (IVD) market during 2013 came from emerging markets while developed nation markets grew at a much slower pace. All of the major IVD companies reported large increases in the top seven emerging markets. This is mostly fueled by privatization and health insurance initiatives by governments and employers. Medicare price cutting in the U.S. is expected to continue, and the IVD market in Europe should remain essentially flat for the next few years. 

According to Kalorama Information’s biennial survey of the IVD industry, The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition, China, Brazil and Korea were among the countries that received industry interest in the form of acquisitions, partnerships and expanded sales efforts.

Topics: Diagnostics Healthcare

Veterinary Diagnostics: Disease Threats to Animals Continues to Boost Need for New Tests

The diseases that can affect cattle, pigs and other livestock and endanger the food supply are numerous, yet still growing. Swine fever, neosporosis, foot-and-mouth disease and other diseases are among the threats to animals that humans eat. Test makers have answered the call to develop products that can help food manufacturers and government agencies protect livestock and ensure a safe food supply at the beginning of the chain. For this reason, the Veterinary Diagnostics market can expect healthy revenue growth, according to insights from a Kalorama Information report on the topic.

Topics: Diagnostics Pets Kalorama Information